BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 9570393)

  • 1. Positive correlation between inhibitors of matrix metalloproteinase 1 and matrix metalloproteinases in malignant ovarian tumor tissues.
    Kikkawa F; Tamakoshi K; Nawa A; Shibata K; Yamagata S; Yamagata T; Suganuma N
    Cancer Lett; 1997 Nov; 120(1):109-15. PubMed ID: 9570393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells.
    Janowska-Wieczorek A; Marquez LA; Matsuzaki A; Hashmi HR; Larratt LM; Boshkov LM; Turner AR; Zhang MC; Edwards DR; Kossakowska AE
    Br J Haematol; 1999 May; 105(2):402-11. PubMed ID: 10233411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
    Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
    Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy.
    Riley SC; Leask R; Chard T; Wathen NC; Calder AA; Howe DC
    Mol Hum Reprod; 1999 Apr; 5(4):376-81. PubMed ID: 10321811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases and their inhibitors.
    Kugler A
    Anticancer Res; 1999; 19(2C):1589-92. PubMed ID: 10365151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells].
    Kikkawa F
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):618-22. PubMed ID: 8808829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form.
    Tamakoshi K; Kikkawa F; Nawa A; Ishikawa H; Mizuno K; Tamakoshi A; Yamagata S; Suganuma N; Tomoda Y
    Cancer; 1995 Dec; 76(12):2565-71. PubMed ID: 8625086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of tissue inhibitor of metalloproteinase-1, -2, and -3 during neointima formation in organ cultures of human saphenous vein.
    Kranzhöfer A; Baker AH; George SJ; Newby AC
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):255-65. PubMed ID: 9974405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy.
    Thomas CV; Coker ML; Zellner JL; Handy JR; Crumbley AJ; Spinale FG
    Circulation; 1998 May; 97(17):1708-15. PubMed ID: 9591765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
    Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
    Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMP and TIMP expression pattern in pleural effusions of different origins.
    Eickelberg O; Sommerfeld CO; Wyser C; Tamm M; Reichenberger F; Bardin PG; Solèr M; Roth M; Perruchoud AP
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1987-92. PubMed ID: 9412584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2.
    Olson MW; Gervasi DC; Mobashery S; Fridman R
    J Biol Chem; 1997 Nov; 272(47):29975-83. PubMed ID: 9368077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T; Okada Y; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases-2 and -9, and tissue inhibitor of metalloproteinases-1 of the sheep placenta during the last third of gestation.
    Vagnoni KE; Zheng J; Magness RR
    Placenta; 1998 Sep; 19(7):447-55. PubMed ID: 9778117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain.
    Rosenberg GA; Estrada EY; Dencoff JE
    Stroke; 1998 Oct; 29(10):2189-95. PubMed ID: 9756602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 72-kD (MMP-2) and 92-kD (MMP-9) type IV collagenase production and activity in different histologic types of lung cancer cells.
    González-Avila G; Iturria C; Vadillo F; Terán L; Selman M; Pérez-Tamayo R
    Pathobiology; 1998; 66(1):5-16. PubMed ID: 9577961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
    Furuya M; Ishikura H; Kawarada Y; Ogawa Y; Sakuragi N; Fujimoto S; Yoshiki T
    Gynecol Oncol; 2000 Aug; 78(2):106-12. PubMed ID: 10926788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and activity of MMPS and their regulators in ovarian cancer.
    Naylor MS; Stamp GW; Davies BD; Balkwill FR
    Int J Cancer; 1994 Jul; 58(1):50-6. PubMed ID: 8014015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.